Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05925101 · ClinicalTrials.gov registry record · NA

Basic and Applied Research on Extinction Bursts

A NA study of Aggression and Problem Behavior, sponsored by Rutgers, The State University of New Jersey.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05925101 is a NA study of Aggression and Problem Behavior that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 40 participants, below the 153-participant average among 21 other Aggression trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05925101, a NA study of Aggression and Problem Behavior, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Although highly effective, treatments like FCT include extinction, which can have adverse side effects. The extinction burst, an increase in the frequency or intensity of destructive behavior at the start of treatment, is the most common side effect of extinction, and can increase the risk of harm to the patient and others. The goal of the current study is to evaluate the prevalence of extinction bursts when various parameters of reinforcement (i.e., rate, magnitude, quality) are manipulated.

Interventions

  • BEHAVIORAL Extinction-only condition
  • BEHAVIORAL Rate-drop condition
  • BEHAVIORAL Rate-hold condition
  • BEHAVIORAL Magnitude-drop condition
  • BEHAVIORAL Magnitude-hold condition

Study Locations (1)

New Jersey

  • Children's Specialized Hospital-Rutgers University Center for Autism Research, Education, and Services - Somerset

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-07-07
Est. Completion 2028-05-31
Phase NA

What the Registry Record Tells You About NCT05925101

The ClinicalTrials.gov registry entry for NCT05925101 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 153-participant average among 21 other Aggression trials with a reported enrollment target (74% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Aggression appearing as the primary indexed condition, and to 5 interventions - of which Extinction-only condition is the first listed.

NCT05925101 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.

Frequently Asked Questions

What is clinical trial NCT05925101 about?

NCT05925101 is a clinical study titled "Basic and Applied Research on Extinction Bursts". Although highly effective, treatments like FCT include extinction, which can have adverse side effects. The extinction burst, an increase in the frequency or intensity of destructive behavior at the start of treatment, is the most common side effect of extinction, and can increase the risk of harm t...

What is the current status of trial NCT05925101?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-07-07. Estimated completion is 2028-05-31.

What conditions does trial NCT05925101 study?

This clinical trial studies the following conditions: Aggression, Problem Behavior, Self-Injury.

What interventions are being tested in trial NCT05925101?

The interventions under investigation include: Extinction-only condition (BEHAVIORAL), Rate-drop condition (BEHAVIORAL), Rate-hold condition (BEHAVIORAL), Magnitude-drop condition (BEHAVIORAL), Magnitude-hold condition (BEHAVIORAL).

Who is sponsoring clinical trial NCT05925101?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05925101 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aggression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.